Sixth Annual Providence Thoracic Oncology Symposium

Providence Cancer Center offered this state-of-the-art symposium to lung cancer specialists in the Pacific Northwest on November 17, 2007. 

The most recent technological advances in pulmonology, thoracic surgery, interventional pulmonology and radiation oncology were presented by internationally renowned physicians who share Providence Thoracic Oncology Program's  dedication to advancing state-of-the-art care for lung cancer patients nationwide.

Follow the links below to view the symposium presentations in their entirety.

These files are best viewed with a high-speed internet connection. Download times may vary.

This program was made possible through educational grants from Sanofi-Aventis, OSI Pharmaceuticals, Inc.; Genentech; Eli Lilly; Onyx-Pharmaceuticals, GlaxoSmithKline; and Bayer Healthcare.

Peter Mazzone, M.D., M.P.H.
The Cleveland Clinic

Preoperative Evaluation for Lung Cancer

  • The literature that guides decisions regarding fitness for lung resection
  • Guidelines that are based on the lung resection literature
  • The means available to optimize the outcome of a patient undergoing lung resection
  • Alternatives to conventional resection

Dr. Mazzone is the director of the Lung Cancer Program for the Department of Pulmonary, Allergy, and Critical Care Medicine at the Cleveland Clinic.

John R. Handy, Jr., M.D.
Co-director, Providence Thoracic Oncology Program
Director, Providence Thoracic Surgery Program
Thoracic Surgeon, The Oregon Clinic

Outcomes in the Marginal Lung Cancer Surgery Patient

  • Surgical risk assessment in preparation for lung surgery
  • The important outcomes of lung cancer surgery
  • The outcomes of lung cancer surgery, especially regarding the marginal patient

Dr. Handy has a special interest in cancers of the chest, with an emphasis on advanced surgical techniques. He has specialized expertise in minimally invasive surgery.

Michael Skokan, M.D.
Pulmonologist, The Oregon Clinic

The Use of Endobronchial Ultrasound (EBUS) in Diagnosis and Management of Lung Cancer

  • Overview of literature supporting use of EBUS in diagnosis and staging on NSCLC
  • Review of available modalities of EBUS: both dedicated needle-aspiration scope and mini-probe technology
  • Demonstration of how the actual procedure is performed

Dr. Skokan’s interests include interventional bronchoscopy, lung cancer evaluation and treatment and critical care medicine.

Alex Gottschalk, M.D., Ph.D.
University of California, San Francisco

Stereotactic Radiosurgery for Lung Cancer

  • What is stereotactic radiosurgery?
  • Local control and overall survival with convention radiation
  • Published results and toxicity of stereotactic radiosurgery for early stage lung cancer
  • A comparison of doses delivered using conventional radiation versus stereotactic radiosurgery

Dr. Gottschalk is Assistant Professor in Residence, Step 3, Department of Radiation Oncology School of Medicine at University of California, San Francisco.

John R. Handy, Jr., M.D.
Co-director, Providence Thoracic Oncology Program
Director, Providence Thoracic Surgery Program
Thoracic Surgeon, The Oregon Clinic

Providence Thoracic Oncology Program as a Regional Resource

In his role as the medical director of Providence Thoracic Surgery Program and the co-medical director of Providence Thoracic Oncology Program, Dr. Handy has led efforts to develop national and institution-based protocols to improve patient selection guidelines and treatment outcomes. 

Hiran C. Fernando, M.D.
Boston Medical Center

Alternative Surgical Therapies to Lobectomy for NSCLC

  • Surgical alternatives for the high-risk patient with NSCLC
  • RFA, sublobar resection and brachytherapy, cyberknife

Dr. Fernando practices cardiothoracic surgery at Boston Medical Center. He is also associate professor and director of Minimally Invasive Surgery. 

Steven Seung, M.D., Ph.D.
Gamma Knife Center of Oregon
Radiation Oncologist, The Oregon Clinic

Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy

  • Effect of high dose radiation on tumor cells and its immunogenicity
  • SBRT and its potential implications for immunotherapy
  • Future plans for SBRT/immunotherapy at Earle A. Chiles Research Center

Dr. Seung earned his Ph.D. and medical degree from the University of Chicago. He completed his residency in radiation oncology at the University of California - San Francisco, where he also received his Gamma Knife training. Board certified in radiation oncology, Dr. Seung practices with The Oregon Clinic and is director of the Gamma Knife Center of Oregon.